Comparison · NCT05481216-4bc4da80
PLWHIV With COVID-19 Cases vs HIV Seronegative Patients With COVID-19 Controls: Need for Kidney Replacement Therapy
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. PLWHIV With COVID-19 Cases vs HIV Seronegative Patients With COVID-19 Controls: Need for Kidney Replacement Therapy. Trial comparisons, record NCT05481216-4bc4da80. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT05481216-4bc4da80
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.101 | 0.0598 | 0.165 | wilson | |
| Risk in group 2 | 0.0465 | 0.0215 | 0.0978 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0543 | -0.0113 | 0.123 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 2.17 | 0.85 | 5.52 | log | |
| Odds ratio, group 1 over group 2 | 2.3 | 0.845 | 6.25 | log | |
| Number needed to treat, for one more participant with the outcome on PLWHIV With COVID-19 Cases than on HIV Seronegative Patients With COVID-19 Controls | 18.4 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | PLWHIV With COVID-19 Cases | Patients who are at least 18 years of age with documented HIV-1 infection and confirmed SARS-CoV-2 infection by documented, or patient-reported, positive result on PCR testing of a nasopharyngeal or respiratory sample, before 1st April 2021.~COVID-19: Diagnosed with COVID-19 infection~HIV-1 infection: Diagnosed with HIV-1 infection | 13 | 129 | OG000 |
| Group 2 | HIV Seronegative Patients With COVID-19 Controls | Patients at least 18 years of age with confirmed SARS-CoV-2 infection by documented, or patient-reported, positive result on PCR testing of a nasopharyngeal or respiratory sample, before 1st April 2021.~COVID-19: Diagnosed with COVID-19 infection | 6 | 129 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Need for Kidney Replacement Therapy
- Description
- The number of patients requiring kidney replacement therapy
- Time frame
- Baseline(diagnosis of COVID-19) to week 6
- Population
This measure was analysed for participants with COVID-19. It is not applicable for COVID-19- participants and not reported for the HIV+COVID-19- arm. Kidney replacement data was not available for all participants in the HIV+COVID+ and HIV-COVID+ groups due to the retrospective nature of this study, and was only collected for 129 participants per group.
Source ClinicalTrials.gov
Trial
- Title
- HIV-1 & Coronavirus-Coinfection in Europe: Morbidity & Risk Factors of COVID-19 in People Living With HIV
- NCT number
- NCT05481216
- Phases
- Conditions
- HIV-1-infection, COVID-19
- Interventions
- COVID-19, HIV-1 infection
- Lead sponsor
- NEAT ID Foundation
- Results first posted
- 2025-03-24
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT05481216?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT05481216-4bc4da80